Actavis Only Requires Scrutiny Of Cash Deals, Judge Says
By Dan Prochilo ( January 24, 2014, 10:24 PM EST) -- A New Jersey federal judge on Friday again dismissed a proposed antitrust class action against GlaxoSmithKline LLC and Teva Pharmaceutical Industries Ltd. over their agreement postponing the production of a generic epilepsy drug, saying a Supreme Court decision changing the way to evaluate such deals' legality led him to the same conclusion....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.